Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMYT

Amryt Pharma (AMYT) Stock Price, News & Analysis

Amryt Pharma logo

About Amryt Pharma Stock (NASDAQ:AMYT)

Advanced Chart

Key Stats

Today's Range
$14.63
$14.76
50-Day Range
$14.55
$14.70
52-Week Range
$6.41
$14.77
Volume
2.39 million shs
Average Volume
757,360 shs
Market Capitalization
$940.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter.

AMYT Stock News Headlines

Alembic Pharmaceuticals Ltd.
AMYT Historical Data
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
Amryt Pharma Stock (NASDAQ:AMYT), Dividends
See More Headlines

AMYT Stock Analysis - Frequently Asked Questions

Amryt Pharma plc (NASDAQ:AMYT) released its earnings results on Thursday, November, 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.73) by $0.66. The firm earned $49.33 million during the quarter. Amryt Pharma had a positive trailing twelve-month return on equity of 1.70% and a negative net margin of 8.19%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amryt Pharma investors own include Alibaba Group (BABA), Dynavax Technologies (DVAX), Advanced Micro Devices (AMD), Teladoc Health (TDOC), NIO (NIO), Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2020
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AMYT
CIK
1783010
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1 million
Pretax Margin
-0.56%

Debt

Sales & Book Value

Annual Sales
$222.54 million
Cash Flow
$0.98 per share
Price / Cash Flow
14.98
Book Value
$5.58 per share
Price / Book
2.63

Miscellaneous

Free Float
60,343,000
Market Cap
$940.21 million
Optionable
Not Optionable
Beta
0.84
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:AMYT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners